Genetic labeling does not detect epithelial-to-mesenchymal transition of cholangiocytes in liver fibrosis in mice

Gastroenterology. 2010 Sep;139(3):987-98. doi: 10.1053/j.gastro.2010.05.005. Epub 2010 Jun 20.

Abstract

Background & aims: Chronic injury changes the fate of certain cellular populations, inducing epithelial cells to generate fibroblasts by epithelial-to-mesenchymal transition (EMT) and mesenchymal cells to generate epithelial cells by mesenchymal-to-epithelial transition (MET). Although contribution of EMT/MET to embryogenesis, renal fibrosis, and lung fibrosis is well documented, role of EMT/MET in liver fibrosis is unclear. We determined whether cytokeratin-19 positive (K19(+)) cholangiocytes give rise to myofibroblasts (EMT) and/or whether glial fibrillary acidic protein positive (GFAP(+)) hepatic stellate cells (HSCs) can express epithelial markers (MET) in response to experimental liver injury.

Methods: EMT was studied with Cre-loxP system to map cell fate of K19(+) cholangiocytes in K19(YFP) or fibroblast-specific protein-1 (FSP-1)(YFP) mice, generated by crossing tamoxifen-inducible K19(CreERT) mice or FSP-1(Cre) mice with Rosa26(f/f-YFP) mice. MET of GFAP(+) HSCs was studied in GFAP(GFP) mice. Mice were subjected to bile duct ligation or CCl(4)-liver injury, and livers were analyzed for expression of mesodermal and epithelial markers.

Results: On Cre-loxP recombination, >40% of genetically labeled K19(+) cholangiocytes expressed yellow fluorescent protein (YFP). All mice developed liver fibrosis. However, specific immunostaining of K19(YFP) cholangiocytes showed no expression of EMT markers alpha-smooth muscle actin, desmin, or FSP-1. Moreover, cells genetically labeled by FSP-1(YFP) expression did not coexpress cholangiocyte markers K19 or E-cadherin. Genetically labeled GFAP(GFP) HSCs did not express epithelial or liver progenitor markers in response to liver injury.

Conclusion: EMT of cholangiocytes identified by genetic labeling does not contribute to hepatic fibrosis in mice. Likewise, GFAP(Cre)-labeled HSCs showed no coexpression of epithelial markers, providing no evidence for MET in HSCs in response to fibrogenic liver injury.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bile Ducts / surgery
  • Biomarkers / metabolism
  • Calcium-Binding Proteins / genetics
  • Carbon Tetrachloride
  • Cell Lineage
  • Cell Transdifferentiation* / genetics
  • Chemical and Drug Induced Liver Injury / genetics
  • Chemical and Drug Induced Liver Injury / metabolism
  • Chemical and Drug Induced Liver Injury / pathology*
  • Collagen Type II / genetics
  • Crosses, Genetic
  • Disease Models, Animal
  • Epithelial Cells / metabolism
  • Epithelial Cells / pathology*
  • Fibroblasts / metabolism
  • Fibroblasts / pathology*
  • Genes, Reporter
  • Glial Fibrillary Acidic Protein / genetics
  • Hepatic Stellate Cells / pathology
  • Immunohistochemistry
  • Keratin-19 / genetics
  • Ligation
  • Liver / metabolism
  • Liver / pathology*
  • Liver Cirrhosis / genetics
  • Liver Cirrhosis / metabolism
  • Liver Cirrhosis / pathology*
  • Liver Regeneration* / genetics
  • Luminescent Proteins / biosynthesis
  • Luminescent Proteins / genetics
  • Mice
  • Mice, Transgenic
  • Promoter Regions, Genetic
  • Proteins / genetics
  • RNA, Untranslated
  • S100 Calcium-Binding Protein A4
  • S100 Proteins

Substances

  • Biomarkers
  • Calcium-Binding Proteins
  • Collagen Type II
  • Glial Fibrillary Acidic Protein
  • Gt(ROSA)26Sor non-coding RNA, mouse
  • Keratin-19
  • Luminescent Proteins
  • Proteins
  • RNA, Untranslated
  • S100 Calcium-Binding Protein A4
  • S100 Proteins
  • S100a4 protein, mouse
  • Carbon Tetrachloride